Susie Wiles has remained a central figure in the Trump administration since taking office in January 2025, with analysts noting her unusually long tenure and the second term’s lower senior staff turnover compared with the first. In mid-September 2026 she announced that she is cancer-free following early-stage breast cancer treatment that began after her March diagnosis, while reiterating her commitment to advancing the president’s agenda. Earlier rumors of a potential post-midterm departure were publicly rejected by Wiles in June as unfounded, and no subsequent official statements or procedural signals have indicated an exit. These developments, combined with Trump’s repeated public praise of her performance and the value placed on continuity ahead of the midterms, underpin trader expectations that she will continue in the role through December 31.